As more international patients begin exploring cancer treatments in China, the demand for cross-border medical care continues to grow.

As a cross-border medical collaboration platform connecting international patients with Chinese healthcare resources, DengYueMed helps overseas patients access hospitals, specialists, and advanced treatment options in China, while also assisting with medical record pre-assessment, treatment consultations, medical translation, and travel-related treatment coordination.

For many overseas patients, seeking cancer treatment in China is not only about lower costs. More importantly, it may offer:

●  Faster access to innovative therapies and new drugs

●  Broader indications for certain treatments

●  Extensive clinical experience

●  Mature multidisciplinary team (MDT) collaboration

●  Shorter waiting times compared with some Western countries

So, what advanced cancer therapies are currently available in China, and which international patients may benefit from them?

CAR-T Cell Therapy: A Major Breakthrough for Hematologic Malignancies

What Is CAR-T?

CAR-T (Chimeric Antigen Receptor T-cell Therapy) is a form of cellular immunotherapy.

Doctors first collect T cells from the patient’s body and genetically engineer them to recognize cancer cells more precisely. These modified immune cells are then reinfused into the patient to attack tumor cells.

Currently, CAR-T therapy has shown the clearest clinical benefits in:

●  Relapsed or refractory lymphoma

●  Acute leukemia

●  Multiple myeloma

China has become one of the world’s most active countries in CAR-T clinical research, with multiple CAR-T products already approved for clinical use.

Which International Patients May Be Suitable?

CAR-T therapy is generally considered for:

●  Patients with hematologic cancers who have failed multiple lines of treatment

●  Patients unable to tolerate further conventional chemotherapy

●  Patients seeking innovative immunotherapy options

●  Patients facing long waiting times for CAR-T treatment in their home countries

For some international patients, China’s CAR-T programs may also offer:

●  Faster treatment timelines

●  Lower costs compared with the United States or Europe

●  Greater access to clinical trials

However, CAR-T is not suitable for all cancers. Its application in solid tumors such as lung cancer, pancreatic cancer, and liver cancer remains largely in the clinical research stage.

Immunotherapy: Reactivating the Body’s Anti-Cancer Immune Response

What Is Immunotherapy?

Immunotherapy works by activating the body’s immune system to recognize and attack cancer cells more effectively.

The most common types currently include:

●  PD-1 inhibitors

●  PD-L1 inhibitors

●  CTLA-4 inhibitors

In recent years, China has approved a large number of immunotherapy drugs, which are now widely used in the treatment of:

●  Lung cancer

●  Liver cancer

●  Melanoma

●  Nasopharyngeal carcinoma

●  Esophageal cancer

●  Gastric cancer

●  Kidney cancer

Some domestically developed PD-1 therapies in China have also accumulated substantial clinical data in Asian patient populations.

Which International Patients May Be Suitable?

Immunotherapy may be particularly suitable for:

●  Patients with advanced-stage cancers

●  Patients who are not candidates for surgery

●  Patients with limited response to chemotherapy

●  Patients seeking long-term disease control

However, not all patients are suitable candidates for immunotherapy.

Treatment eligibility often requires evaluation based on:

●  PD-L1 expression

●  Genetic testing

●  MSI/TMB status

●  Tumor type

Proton and Heavy Ion Therapy: High-Precision Radiation Treatment

What Is Proton or Heavy Ion Therapy?

Proton and heavy ion therapy are among the most advanced forms of radiation therapy currently available worldwide.

Compared with conventional radiotherapy, their major advantages include:

●  Greater precision

●  Reduced damage to surrounding healthy tissues

●  Lower risk of side effects

Their effectiveness is largely based on the Bragg Peak effect, which allows radiation energy to be deposited more precisely at the tumor site.

Although radiation therapy involves highly complex physical modeling, proton beams can release energy at specific tissue depths, thereby minimizing injury to nearby healthy organs.

Which Cancers Are More Suitable?

These therapies are especially suitable for:

●  Nasopharyngeal carcinoma

●  Brain tumors

●  Pediatric cancers

●  Chordoma

●  Prostate cancer

●  Liver cancer

●  Pancreatic cancer

●  Tumors located near critical organs

China has established several proton and heavy ion therapy centers, including the Shanghai Proton and Heavy Ion Center, which is widely recognized in Asia.

Which International Patients May Benefit?

These therapies may be appropriate for:

●  Patients hoping to reduce radiation-related side effects

●  Pediatric patients

●  Patients with tumors in anatomically complex locations

●  Patients with recurrent tumors after previous radiation therapy

●  Patients requiring maximum preservation of organ function

For many international patients, proton therapy costs in China are also significantly lower than those in the United States.

NanoKnife (Irreversible Electroporation): A New Option for Unresectable Tumors

What Is NanoKnife?

NanoKnife, also known as Irreversible Electroporation (IRE), is a minimally invasive tumor ablation technology.

Rather than surgically removing tumors, it uses high-voltage electrical pulses to disrupt cancer cell membranes and induce cell death.

Its major advantages include:

●  Ability to avoid damaging blood vessels and nerves

●  Reduced injury to surrounding tissues

●  Suitability for tumors in complex anatomical locations

Which Cancers Is It Commonly Used For?

NanoKnife is mainly used in:

●  Pancreatic cancer

●  Liver cancer

●  Prostate cancer

●  Selected lung cancers

It is particularly considered for patients with locally advanced tumors that are not surgically resectable but may still benefit from local tumor control.

Which International Patients May Benefit?

This therapy may be suitable for:

●  Patients with locally advanced but non-metastatic disease

●  Patients who are not candidates for surgery

●  Patients seeking minimally invasive treatment options

●  Patients with limited response to conventional therapies

In recent years, China has seen growing clinical application of NanoKnife and other minimally invasive interventional oncology techniques.

Cryoablation: Minimally Invasive Precision Tumor Destruction

Cryoablation destroys tumors by exposing them to extremely low temperatures, causing cancer cell death.

Compared with conventional surgery, it offers:

●  Less trauma

●  Faster recovery

●  The possibility of repeated treatment

It is commonly used in:

●  Lung cancer

●  Liver cancer

●  Kidney cancer

●  Bone metastases

Some studies also suggest that cryoablation may stimulate certain anti-tumor immune responses.

Which Patients May Be Suitable?

Cryoablation may be considered for:

●  Elderly patients unable to tolerate surgery

●  Patients with small localized tumors

●  Patients seeking palliative treatment to improve quality of life

Precision Targeted Therapy: Personalized Treatment Based on Genetic Testing

Modern oncology has increasingly entered the era of genomic medicine.

Through:

●  Next-Generation Sequencing (NGS)

●  Molecular profiling

●  Biomarker analysis

doctors can identify targeted therapies tailored to individual patients.

China currently has extensive research and drug development in targets such as:

●  EGFR

●  ALK

●  ROS1

●  HER2

●  KRAS

●  RET

Which Patients May Benefit?

Precision targeted therapy is especially relevant for:

●  Lung cancer patients

●  Certain breast cancer patients

●  Colorectal cancer patients

●  Ovarian cancer patients

Compared with traditional chemotherapy, targeted therapies often have fewer systemic side effects. However, patients must carry the relevant molecular targets to benefit from treatment.

Why Is China Attracting More International Cancer Patients?

In recent years, more international patients have sought cancer treatment in China for several reasons.

1. Rapid Development of Innovative Therapies

China has made rapid progress in:

●  CAR-T therapy

●  Immunotherapy

●  Particle radiation therapy

●  Minimally invasive interventional oncology

2. More Manageable Treatment Costs

Many advanced therapies remain significantly less expensive than in Western countries.

3. Extensive Clinical Experience

China’s large cancer patient population has enabled major oncology centers to accumulate substantial clinical experience.

4. Mature MDT (Multidisciplinary Team) Model

Many hospitals have established MDT systems integrating:

●  Medical oncology

●  Surgical oncology

●  Radiation oncology

●  Imaging

●  Pathology

●  Nutrition and rehabilitation

to develop comprehensive treatment plans collaboratively.

Which International Patients May Consider Cancer Treatment in China?

Patients who may particularly consider treatment in China include:

●  Patients with limited treatment options in their home countries

●  Patients seeking access to advanced therapies

●  Patients with relapsed or refractory cancers

●  Patients hoping to reduce treatment costs

●  Patients seeking second medical opinions

●  Patients interested in clinical trials

However, cross-border medical care is not suitable for everyone.

Patients are usually advised to prepare:

●  Pathology reports

●  Imaging records

●  Previous treatment history

●  Genetic testing results

●  Current health assessments

so hospitals can conduct an initial medical evaluation.

Conclusion

As cancer treatment continues moving toward precision medicine and innovative therapies worldwide, China is gradually becoming an increasingly important destination for international cancer patients.

From CAR-T therapy and immunotherapy to proton and heavy ion radiation therapy and minimally invasive interventional oncology, major cancer centers in China have accumulated substantial clinical experience while continuing to adopt emerging technologies.

For many overseas patients, cross-border cancer treatment is not only about accessing new medical opportunities, but also about navigating hospital selection, treatment communication, medical documentation, and travel coordination.

Through cross-border medical collaboration services, DengYueMed aims to help international patients better understand China’s healthcare system and connect with hospitals, physicians, and treatment resources more efficiently, allowing patients to make more informed treatment decisions with clearer access to medical information.

As innovation and international medical collaboration continue to expand, advanced cancer therapies in China may provide new treatment opportunities and hope for more patients worldwide.

Related Articles:

1.      Approved Cell and Gene Therapy Drugs in China and Key Differences Between Cell Therapy and Gene Therapy

2.      Approved Immune Checkpoint Inhibitors in China: PD-1, PD-L1, CTLA-4 and Bispecific Antibodies

3.      Top 10 Hospitals in China for International Patients

4.      Complete Guide to Cancer Treatment in China for International Patients

5.      Modern Cancer Treatment in China: An International Guide to CAR-T, Immunotherapy, and Emerging Therapies